Mutant Organophosphorus Acid Anhydrolase Enzymes for V-Agent Degradation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organophosphorus acid anhydrolases have limited catalytic activity against highly toxic and persistent V-type chemical warfare agents, such as VX, making them ineffective for decontamination and medical countermeasures.
Innovation Solution
Development of mutant organophosphorus acid anhydrolase enzymes with specific amino acid substitutions at positions 212, 215, 342, and 343, which significantly enhance catalytic efficiency against V-type agents, including VX, VR, CVX, and VM, by increasing the enzymes' ability to degrade these compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If wild-type organophosphorus acid anhydrolase is used, then the enzyme can degrade G-type nerve agents and pesticides, but it has only marginally detectable activity against V-agents such as VX
Solution Approach 1:
The patent applies parameter changes by modifying specific amino acid residues at positions 212, 215, 342, and 343 in the OPAA enzyme sequence. These mutations alter the enzyme's catalytic properties, specifically enhancing its activity toward V-agents while preserving its ability to degrade other organophosphorus compounds. The systematic variation of amino acid parameters at key positions enables the enzyme to achieve practical catalytic efficiency against VX and related compounds.
2Reliability
If a single mutation at position 212 is introduced, then the enzyme can degrade V-agents with about 2-fold activity, but the catalytic efficiency remains insufficient for practical decontamination
Solution Approach 1:
The patent merges multiple beneficial mutations at positions 212, 215, 342, and 343 into a single enzyme variant. By combining these mutations synergistically, the enzyme achieves catalytic efficiency enhancements of 10-fold or greater against V-agents, transforming it into a practically useful decontaminant. The combined effect of multiple mutations exceeds the sum of individual mutation effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutant enzymes exhibit substantial increases in catalytic efficiency, with FLYA showing a 33-fold increase on VR and 11-fold increase on VX, FLYG showing 20-fold on VR and 18-fold on VX, and FLYD-Q showing 16-fold on VM, effectively degrading these hazardous agents.
Implementation Method 1
a class of enzymes known as organophosphorus acid ('OPA') anhydrolases ('OPAA') (EC 3.1.8.2) can catalyze the hydrolysis of a variety of OP compounds
Implementation Method 2
The mutant OPAA enzyme FLYA (SEQ ID NO: 2) exhibits a 33-fold increase in catalytic efficiency on VR and an 11-fold increase in catalytic efficiency on VX
Data Source
AI summary
The invention is directed toward mutant, non-wild-type organophosphorus acid anhydrolases (OPPAs) having three or more site mutations, methods of production, kits and methods of use to effectively degrade toxic V-agent type chemical compounds such as VX, VR, CVX, and VM.